Replies to post #38023 on Cytodyn Inc (CYDY)

[Evil Rabbit]

You admit to criticizing Chump but don’t like it when others criticize you. Double standard much? At least Chump isn’t trying to dupe anybody into selling.

[chumppunk]

Fine- First, Evil thank you. I can handle this. CYDY had an awesome week and mgmnt is at an all time high of prospects for the company in many areas. Fine, I don't debate you, I disqualify you and from your first post. Don't really care who here agrees or not with me. I've heard compile from you a hundred times and wonder if you know your audience. Your antiquated word press, PHP blog should be your concern. My telegraph posts are nothing like your <01>, <08> ghost sidekicks you try and sell us on. Your coding, programming, blogging, compiling info is amateur at best.
]
If you uncomment the #include <iostream> statement then it will compile. In other words, it just so happens that iostream internally includes a #include <string> statement and your code will compile.

//#include <iostream>
using namespace std;
int main() {
string test = "test";
return 0;
}
Whoever taught you that it is ok to use global variables has done a disservice to you.
In other words, I'm not impressed with you as some here is. It is Mardi Gra here in NOLA or I would actually take the time to explain what is to unfold, hopefully without you.
Chump

[BlackDoggie]

I tend to think that enrollment isn’t an issue, but getting every last detail of the trial procedures is probably extremely important. Remember, Pestell seemed surprised at how quickly the FDA approved the IND. This needs to be done 100% correct the first time - I doubt the patients are the hang up.

Otherwise, you end up in the situation we’re in now where we need more data from mono patients for HIV to support the combo BLA, because they failed to do a proper dose escalation phase in combo from the start.

Maybe that’s semantics (enrollment vs. getting the details right), but it makes a difference to me after the difficulty enrolling the combo P3!